Phospholipid storage in the myocardium of a unique Japanese case of idiopathic cardiomyopathy.

A unique adult male patient who developed cardiomyopathy was first suspected to have cardiac Fabry disease based on the pathological findings in heart tissues obtained on biopsy, but the alpha-galactosidase activity in his leukocytes was normal and no mutation was detected in the coding region of the alpha-galactosidase gene. We identified accumulated materials in the myocardium of this patient.
Pathological and biochemical analyses were performed using the autopsied heart tissues as samples.
Although numerous lamellar and concentric inclusion bodies were ultrastructurally found in the autopsied myocardium, the alpha-galactosidase activity in the heart tissues was not decreased. Lipid analysis revealed the accumulation of phospholipids including phosphatidylethanolamine, phosphatidylcholine, and phosphatidylinositol, but not globotriaosylcereamide or gangliosides.
We found that a large amount of phospholipids accumulated in the myocardium of a patient with idiopathic cardiomyopathy, and electron microscopic findings of lamellar and concentric inclusion bodies in cardiomyocytes. A cardiac phospholipid storage disorder should be considered as an important candidate disease on differential diagnosis of myocardiac disorders including cardiac Fabry disease.
AuthorsIkuo Kawashima, Ichiro Takeuchi, Mai Ohsawa, Masaharu Kotani, Youichi Tajima, Takayuki Inomata, Tohru Izumi, Hitoshi Sakuraba
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 372 Issue 1-2 Pg. 154-7 (Oct 2006) ISSN: 0009-8981 [Print] Netherlands
PMID16753138 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phospholipids
  • alpha-Galactosidase
  • Autopsy
  • Cardiomyopathies (enzymology, metabolism, pathology)
  • Chromatography, Thin Layer
  • Humans
  • Male
  • Middle Aged
  • Phospholipids (metabolism)
  • alpha-Galactosidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: